Ignite Creation Date:
2024-05-06 @ 3:11 PM
Last Modification Date:
2024-10-26 @ 1:44 PM
Study NCT ID:
NCT04540211
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-05-13
First Post:
2020-09-03
Brief Title:
A Study of Atezolizumab Plus Tiragolumab in Combination With Paclitaxel and Cisplatin Compared With Paclitaxel and Cisplatin as First-Line Treatment in Participants With Unresectable Locally Advanced Unresectable Recurrent or Metastatic Esophageal Carcinoma
Sponsor:
Hoffmann-La Roche
Organization:
Hoffmann-La Roche
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-10-30
Start Date Type:
ACTUAL
Primary Completion Date:
2023-02-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-08-14
Completion Date Type:
ESTIMATED
First Submit Date:
2020-09-03
First Submit QC Date:
September 3 2020
Study First Post Date:
2020-09-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2024-02-09
Disp First Submit QC Date:
February 9 2024
Disp First Post Date:
2024-02-13
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2024-08-08
Last Update Post Date:
2024-05-13
Last Update Post Date Type:
ACTUAL